AG真人官方

Zurn Elkay Water Solutions (NYSE: ZWS) filed a Form 144 indicating an intention by insider Timothy J. Jahnke (and a related trust) to sell restricted stock under Rule 144.

• Planned sale: 143 common shares via Wells Fargo Clearing Services, valued at about $6,424, with an earliest sale date of 4 Aug 2025 on the NYSE.
• The block represents roughly 0.0001 % of the 167,552,517 shares outstanding鈥攆inancially immaterial to the float.
• Origin of shares: acquired 1 Jul 2022 through a merger transaction.
• Recent insider activity: Jahnke entities disposed of 30,000 shares on 30-31 Jul 2025, realising $1.30 million in gross proceeds.

The seller certifies no undisclosed adverse information and may be acting under a Rule 10b5-1 plan. Although the new sale is de-minimis, the continued pattern of insider selling could temper investor sentiment.

Local Bounti Corporation (LOCL) has filed a Form 144 disclosing a planned disposition of restricted stock under Rule 144 of the Securities Act.

Seller: KEBS Trust
Planned sale: 3,500 common shares
Broker: Morgan Stanley Smith Barney, New York
Approximate sale date: 10 July 2025 (on the NYSE)
Aggregate market value: $9,261.35
Shares outstanding: 10,914,704
This transaction equals roughly 0.03 % of the company鈥檚 outstanding stock, indicating minimal dilution risk.

The shares were originally received as a gift from an affiliate on 28 December 2022. KEBS Trust has already executed several open-market sales in the past three months:

• 09 Jul 2025 鈥� 200 shares 鈥� $602.00
• 22 May 2025 鈥� 1,179 shares 鈥� $2,458.33
• 21 May 2025 鈥� 600 shares 鈥� $1,262.52
• 20 May 2025 鈥� 800 shares 鈥� $1,736.72
• 19 May 2025 鈥� 1,000 shares 鈥� $2,226.60
• 16 May 2025 鈥� 1,421 shares 鈥� $3,326.13

Total prior 3-month sales: 5,200 shares for gross proceeds of about $11,612. The signatory affirms no undisclosed adverse information and acknowledges SEC anti-fraud provisions.

On 07/07/2025, FMR LLC 鈥� the parent company of Fidelity Investments 鈥� and its chair & CEO Abigail P. Johnson filed a Schedule 13G disclosing ownership of 5,600,662 common shares of Omada Health, Inc. (OMDA), corresponding to 10.0 % of the outstanding stock as of the event date 06/30/2025.

The filing indicates a passive investment under Rule 13d-1(b). FMR LLC reports sole voting power and sole dispositive power over the entire position, with no shared voting or dispositive authority. Ms. Johnson is deemed a co-reporting beneficial owner because of her control of FMR LLC; she likewise claims sole dispositive power over the same shares.

No purchase price, transaction details, or intent to influence control are provided. The signatories certify that the shares were acquired in the ordinary course of business and not in connection with any control-changing objective or proxy contest. An exhibit lists the subsidiaries through which the securities are held, but those details are not included in the text provided.

Implications for investors:

• A blue-chip institutional investor now holds a double-digit stake, which can enhance market confidence and liquidity.
• Because the filing is on Schedule 13G, FMR signals a passive stance; however, surpassing the 10 % threshold increases its potential influence in future corporate governance matters if it later opts for an active role.
• The concentration of voting rights in a single institution could also become a risk factor should Fidelity decide to trim or exit the position.

The document contains no financial statements, earnings data, or management commentary; it is strictly an ownership disclosure required by SEC rules.